| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| Q96LP1 | CDNA FLJ25336 fis, clone TST00709; HCG2015768; | NULL | NULL | 140 | human |
| A0A024R0D5 | Sodium channel, nonvoltage-gated 1, delta, isoform CRA_a; | SCNN1D; | NULL | 669 | human |
| Q6TV06 | Breast cancer-associated antigen SGA-56M; Smg-7 homolog, nonsense mediated mRNA decay factor (C. elegans), isoform CRA_a; | SGA56M; SMG7; | NP_775179.1; | 802 | human |
| H0UI06 | Cytochrome c oxidase subunit 7A2, mitochondrial; Cytochrome c oxidase subunit VIIa polypeptide 2; Cytochrome c oxidase subunit VIIa polypeptide 2 (Liver), isoform CRA_a; | COX7A2; | NP_001856.2; | 115 | human |
| Q29R61 | PEX11A protein; | PEX11A; | NULL | 205 | human |
| A0A024R7X2 | Telomeric repeat binding factor (NIMA-interacting) 1, isoform CRA_b; | TERF1; | NULL | 455 | human |
| A0A024RB35 | C1q domain containing 1, isoform CRA_g; | C1QDC1; | NULL | 1077 | human |
| L7SRW4 | ATP synthase subunit a; | ATP6; | NULL | 226 | human |
| A4ZKZ1 | ATP synthase protein 8; | ATP8; | NULL | 68 | human |
| A0A024RDS9 | HCG2020254, isoform CRA_a; | NULL | NULL | 124 | human |
| D3DX81 | Procollagen (Type III) N-endopeptidase, isoform CRA_a; Fragment; | PCOLN3; | NULL | 332 | human |
| A0A024R3J7 | HCG2032701, isoform CRA_a; | NULL | NULL | 703 | human |
| A0A024RDB3 | HCG1643496, isoform CRA_a; | NULL | NULL | 50 | human |
| A0A024R1V0 | Breast cancer 1, early onset, isoform CRA_d; | BRCA1; | NULL | 759 | human |
| A0A024RAI4 | Bridging integrator 1, isoform CRA_b; | BIN1; | NULL | 475 | human |
| Q5DSZ9 | HCG2039726, isoform CRA_g; UDP glycosyltransferase 1 family polypeptide A5; | UGT1A5; | NP_061951.1; | 534 | human |
| A0N4Y8 | HCG2039769; Possible J 20 gene segment; Fragment; | Tcr-alpha; | NULL | 18 | human |
| A0A024R8F8 | Endothelial differentiation-related factor 1, isoform CRA_a; | EDF1; | NULL | 308 | human |
| A0A024R3T0 | HCG22297, isoform CRA_a; | NULL | NULL | 22 | human |
| A0A024RCE9 | BR serine/threonine kinase 2, isoform CRA_c; | BRSK2; | NULL | 674 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |